Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM2 | Q14416 | 2/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | CNR2 | P34972 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | F2R | P25116 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7902844 | 0.86 | KCNH2 (0.34) | MEN1KMT2A | |
| SCHEMBL7902228 | 0.86 | KCNH2 (0.34) | MEN1KMT2A | |
| SCHEMBL7902229 | 0.86 | KCNH2 (0.34) | MEN1KMT2A | |
| SCHEMBL7900732 | 0.78 | KCNH2 (0.41) | ALDH1A1MEN1KMT2ATSHR | |
| SCHEMBL7900730 | 0.78 | KCNH2 (0.41) | ALDH1A1MEN1KMT2ATSHR | |
| SCHEMBL7894780 | 0.78 | KCNH2 (0.41) | ALDH1A1MEN1KMT2ATSHR | |
| SCHEMBL7904030 | 0.78 | KCNH2 (0.41) | ALDH1A1MEN1KMT2ATSHR | |
| SCHEMBL7900733 | 0.78 | KCNH2 (0.41) | ALDH1A1MEN1KMT2ATSHR | |
| SCHEMBL7894775 | 0.78 | KCNH2 (0.41) | ALDH1A1MEN1KMT2ATSHR | |
| SCHEMBL22675923 | 0.74 | SOAT1 (0.38) | CNR2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210155641-A1 | METHOD FOR PRODUCING PHOSPHINOBENZENE BORANE DERIVATIVE, METHOD FOR PRODUCING 1,2-BIS(DIALKYLPHOSPHINO)BENZENE DERIVATIVE, AND TRANSITION METAL COMPLEX | NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) | 2021-05-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210155641-A1 | METHOD FOR PRODUCING PHOSPHINOBENZENE BORANE DERIVATIVE, METHOD FOR PRODUCING 1,2-BIS(DIALKYLPHOSPHINO)BENZENE DERIVATIVE, AND TRANSITION METAL COMPLEX | P4HB, PAH, BOLA2; BOLA2B | GRM2 618/4885RECQL 2847/4885ALDH1A1 1734/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.